Clinical Trial Update: Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC [Phase 2]

View source ↗

Summary

Phase 2 trial of vorinostat with chemoradiation for locally advanced head and neck squamous cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-related Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity | Phase 2 | Status: WITHDRAWN